This event aims to bring together more than 1,000 diagnostic professionals to discuss all areas of the comprehensive field of diagnoses. This is an ideal networking event for individuals pursuing diagnostic technologies in all its facets, from research to commercialization.
The event is the region’s largest on-site exhibit in the biomedical research community and expects more than 2,500 research professionals to attend. Over 360 exhibiting companies will be present, with opportunities to connect with researchers from the NIH and its neighboring facilities.
The festival’s wide range of attendees is representative of the diversity in professionals involved in generating, using or studying genomic information. The event is described as a 3-day celebration of genomics, embracing the all aspects of the field from the lab to clinical care.
Hosted by the Mayo Clinic, this conference focuses on the translation of genomic science to clinical care. Strategies to use genomics and pharmacogenomics as a tool for optimal individualized medicine and patient care are at the center of this annual meeting.
Macrogen will be in Booth #1229
This annual meeting expects to host 6,500 attendees, encompassing all areas of human genetics. The event is intended to be a forum for human genetic researchers in the field to discuss and present their most recent findings.
Also, join us October 19th in the Vancouver Convention Centre’s East Building, Room #9, from 1 – 2:30 pm for our free luncheon event on GenomeAsia 100K: Harnessing the Genetic Diversity of Asia to Drive Genomic Medicine
Come join speaker Andrew Peterson, Senior Director of Molecular Biology for Genentech, for “GenomeAsia 100K: Harnessing the Genetic Diversity of Asia to Drive Genomic Medicine.”
Lunch is on us!
The genetic diversity of the human populations of Asia is largely unexplored. Although Asia is a broad region whose diverse populations comprise 40% of the world’s total, few genetic studies have been carried out on Asian populations. GenomeAsia 100K is providing a public resource in the form of a database of genetic variation in Asian populations to facilitate efficient and effective genetic studies to be carried out; studies that will enable prognosis and diagnosis and that will provoke therapeutic discoveries. By sequencing the genomes of 100,000 individuals from diverse populations and health conditions, we are producing a critical resource for effective molecular diagnosis of mendelian disorders. At the same time the consortium will provide the data and resources that will allow studies of complex disease to be designed and carried out in Asia.
A preliminary goal of the GenomeAsia consortium is to produce a framework description of genetic diversity upon which further studies will be built. Our initial efforts have focused on producing high coverage whole genome sequence data of 1800 individuals selected from defined population groups from south, southeast, east and north Asia. The major goal of the consortium is to provide the tools for medically focused studies but we cannot ignore the relevance of this initial data-set to answering questions of human history in Asia. The presentation will focus on describing the goals and strategies of the GenomeAsia consortium and the preliminary analysis of genetic variation across the region and what it tells us about the origins and histories of the peoples of Asia.